Walleye Capital LLC - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K204. A total of 22 filers reported holding PHOENIX BIOTECH ACQUISITION in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2022$501,000
+0.2%
49,6940.0%0.01%
-28.6%
Q2 2022$500,0000.0%49,6940.0%0.01%
+7.7%
Q1 2022$500,000
-0.4%
49,694
-0.1%
0.01%
-18.8%
Q4 2021$502,00049,7360.02%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q3 2022
NameSharesValueWeighting ↓
DIFESA CAPITAL MANAGEMENT, LP 125,000$1,265,0000.64%
Wealthspring Capital LLC 177,300$1,789,0000.35%
Castle Creek Arbitrage, LLC 400,000$4,036,0000.22%
Shaolin Capital Management LLC 750,000$7,568,0000.21%
Schechter Investment Advisors, LLC 149,660$1,510,0000.15%
Yakira Capital Management, Inc. 100,000$1,009,0000.15%
Silver Rock Financial LP 46,243$467,0000.10%
Westchester Capital Management, LLC 150,000$1,518,0000.04%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 16,641$168,0000.02%
Walleye Capital LLC 49,694$501,0000.01%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders